IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharmaceutical Contamination in U.S. Spreads to Germany, China is Prime Suspect

10:13 AM MDT | March 11, 2008 |

Alex Scott

Contaminated batches of the blood thinning drug heparin that are potentially lethal have been discovered on the market in Germany. Producers have recalled supplies of heparin in the country in the past week following severe reactions to batches of the drug by up to 100 patients. The contamination cases in Germany follow the withdrawal at the end of February of contaminated batches of heparin in the U.S. that have been linked to as many as 800 adverse patient reactions and 19 patient deaths. The contaminated heparin used in the U.S. has been traced back to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa